Observational registry for those with recent diagnosis of Fatty Liver/NASH
- Must be followed as part of Standard of Care with one of our physicians AT LEAST ONCE A YEAR
Observational registry for those with Ulcerative Colitis or Crohn's Disease
- Must be under current treatment and being followed as part of Standard of Care with one of our physicians
Seeking Women and Men over the age of 18 with Moderate to Severe Active Ulcerative Colitis.
Do you have a diagnosis of Ulcerative Colitis, with signs and symptoms consistent with UC for at least 3 months?
Have you been diagnosed with moderate to severely active UC disease activity?
If so, you may be eligible to participate in a clinical trial that is exploring the safety and efficacy of an open-label treatment of FDA approved Zeposia (Ozanimod) in participants with Moderate to severe Ulcerative Colitis.
All subjects will undergo a screening colonoscopy for confirmation diagnoses. With a second colonoscopy mid-treatment at week 12 (Cohort 1) or/ week 26 (Cohort 2).
There will be two arms for participants:
- Cohort 1: Participants with moderate to severely active UC who have not been exposed to biologics or immunomodulators for the treatment of UC (ie, advanced therapy-naïve).
- Cohort 2: Participants with moderate to severely active UC who have been exposed to a single mechanism of action of biologics for the treatment of UC (ie, advanced therapy-exposed).
Subjects will complete a screening period which may take up to 28 days. Followed by treatment with Zeposia for two years. A post-treatment follow-up (at 84 days) will complete participation.
All study related procedures and office visits, along with study treatment will be covered under the study with no cost to you as a study participant.
This trial can be further reviewed on https://clinicaltrials.gov/ct2/show/NCT05369832
Other important readings:
See if you qualify by asking your doctor and calling : 727-786-0017 or contacting the research department at Advanced Gastroenterology Associates, LLC 727-216-0768.
One time Blood Specimen study for those diagnosed with Non-Viral Liver Disease
Subjects must not have been diagnosed with Viral Hepatitis (A, B, C, D, E) or HIV
- Alcoholic Hepatitis
- Autoimmune Hepatitis
- Granulomatous Hepatitis
- Hepatocellular Carcinoma
- Obstructive Jaundice
- Wilson’s Disease